{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T18:59:01Z","timestamp":1793127541858,"version":"4.5.0"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T00:00:00Z","timestamp":1750032000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100019688","name":"Functional Genomics Center Zurich","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019688","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004191","name":"Novo Nordisk A\/S","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004191","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Swiss National Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007890","name":"University of North Carolina at Chapel Hill","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007890","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003006","name":"Eidgen\u00f6ssische Technische Hochschule Z\u00fcrich","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003006","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006447","name":"Universit\u00e4t Z\u00fcrich","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006447","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.ebiom.2025.105836","type":"journal-article","created":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T02:26:32Z","timestamp":1751509592000},"page":"105836","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Cagrilintide lowers bodyweight through brain amylin receptors 1 and 3"],"prefix":"10.1016","volume":"118","author":[{"given":"Alexandra Oliveira","family":"Carvas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Leuthardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Kulka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Greta","family":"Lommi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shad","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3747-0076","authenticated-orcid":false,"given":"Bernd","family":"Coester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Lundh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tune","family":"Pers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Secher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7605-8215","authenticated-orcid":false,"given":"Kirsten","family":"Raun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas A.","family":"Lutz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6677-5488","authenticated-orcid":false,"given":"Christelle","family":"Le Foll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10382","key":"10.1016\/j.ebiom.2025.105836_bib2","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/S0140-6736(22)02403-5","article-title":"Contemporary medical, device, and surgical therapies for obesity in adults","volume":"401","author":"Perdomo","year":"2023","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.ebiom.2025.105836_bib3","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/s41574-019-0176-8","article-title":"Obesity: global epidemiology and pathogenesis","volume":"15","author":"Bluher","year":"2019","journal-title":"Nat Rev Endocrinol"},{"issue":"3","key":"10.1016\/j.ebiom.2025.105836_bib4","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.1016\/S2213-8587(24)00316-4","article-title":"Definition and diagnostic criteria of clinical obesity","volume":"13","author":"Rubino","year":"2025","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"10403","key":"10.1016\/j.ebiom.2025.105836_bib5","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/S0140-6736(23)01163-7","article-title":"Efficacy and safety of co-administered once-weekly cagrilintide 2.4 mg with once-weekly semaglutide 2.4 mg in type 2 diabetes: a multicentre, randomised, double-blind, active-controlled, phase 2 trial","volume":"402","author":"Frias","year":"2023","journal-title":"Lancet"},{"issue":"10317","key":"10.1016\/j.ebiom.2025.105836_bib6","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1016\/S0140-6736(21)01999-1","article-title":"Long-acting amylin analogue for weight reduction","volume":"398","author":"Gadde","year":"2021","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.ebiom.2025.105836_bib7","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0021-9975(97)80073-4","article-title":"Detection of amyloid deposition in various regions of the feline pancreas by different staining techniques","volume":"116","author":"Lutz","year":"1997","journal-title":"J Comp Pathol"},{"issue":"5","key":"10.1016\/j.ebiom.2025.105836_bib8","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/0031-9384(94)90076-0","article-title":"Reduction of food intake in rats by intraperitoneal injection of low doses of amylin","volume":"55","author":"Lutz","year":"1994","journal-title":"Physiol Behav"},{"issue":"3","key":"10.1016\/j.ebiom.2025.105836_bib9","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.regpep.2006.06.004","article-title":"Role of endogenous amylin in glucagon secretion and gastric emptying in rats demonstrated with the selective antagonist, AC187","volume":"137","author":"Gedulin","year":"2006","journal-title":"Regul Pept"},{"issue":"3","key":"10.1016\/j.ebiom.2025.105836_bib10","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1002\/j.2040-4603.2020.tb00140.x","article-title":"Systemic and central amylin, amylin receptor signaling, and their physiological and pathophysiological roles in metabolism","volume":"10","author":"Le","year":"2020","journal-title":"Compr Physiol"},{"key":"10.1016\/j.ebiom.2025.105836_bib11","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.molmet.2017.11.009","article-title":"Amylin - its role in the homeostatic and hedonic control of eating and recent developments of amylin analogs to treat obesity","volume":"8","author":"Boyle","year":"2018","journal-title":"Mol Metab"},{"issue":"12","key":"10.1016\/j.ebiom.2025.105836_bib12","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1007\/s00018-011-0905-1","article-title":"Control of energy homeostasis by amylin","volume":"69","author":"Lutz","year":"2012","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.ebiom.2025.105836_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2023.175912","article-title":"Body weight lowering effect of glucose-dependent insulinotropic polypeptide and glucagon-like peptide receptor agonists is more efficient in RAMP1\/3 KO than in WT mice","volume":"955","author":"Leuthardt","year":"2023","journal-title":"Eur J Pharmacol"},{"issue":"6","key":"10.1016\/j.ebiom.2025.105836_bib14","doi-asserted-by":"crossref","first-page":"R1833","DOI":"10.1152\/ajpregu.2001.281.6.R1833","article-title":"Amylin potently activates AP neurons possibly via formation of the excitatory second messenger cGMP","volume":"281","author":"Riediger","year":"2001","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"11","key":"10.1016\/j.ebiom.2025.105836_bib15","doi-asserted-by":"crossref","first-page":"15448","DOI":"10.1096\/fj.202001456RRR","article-title":"Noradrenaline signaling in the LPBN mediates amylin's and salmon calcitonin's hypophagic effect in male rats","volume":"34","author":"Boccia","year":"2020","journal-title":"FASEB J"},{"issue":"6","key":"10.1016\/j.ebiom.2025.105836_bib16","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.2337\/db19-0849","article-title":"Amylin\/calcitonin receptor-mediated signaling in POMC neurons influences energy balance and locomotor activity in chow-fed male mice","volume":"69","author":"Coester","year":"2020","journal-title":"Diabetes"},{"key":"10.1016\/j.ebiom.2025.105836_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2020.107987","article-title":"Salmon calcitonin distributes into the arcuate nucleus to a subset of NPY neurons in mice","volume":"167","author":"Zakariassen","year":"2020","journal-title":"Neuropharmacology"},{"issue":"5","key":"10.1016\/j.ebiom.2025.105836_bib18","doi-asserted-by":"crossref","first-page":"805","DOI":"10.2337\/db17-1347","article-title":"Amylin selectively signals onto POMC neurons in the arcuate nucleus of the hypothalamus","volume":"67","author":"Lutz","year":"2018","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105836_bib19","doi-asserted-by":"crossref","first-page":"4154","DOI":"10.1111\/ejn.15254","article-title":"Whole-brain mapping of amylin-induced neuronal activity in receptor activity-modifying protein 1\/3 knockout mice","volume":"54","author":"Skovbjerg","year":"2021","journal-title":"Eur J Neurosci"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105836_bib20","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/bph.14075","article-title":"Update on the pharmacology of calcitonin\/CGRP family of peptides: IUPHAR Review 25","volume":"175","author":"Hay","year":"2018","journal-title":"Br J Pharmacol"},{"issue":"7","key":"10.1016\/j.ebiom.2025.105836_bib21","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1139\/y95-146","article-title":"Comparative distribution of receptors for amylin and the related peptides calcitonin gene related peptide and calcitonin in rat and monkey brain","volume":"73","author":"Christopoulos","year":"1995","journal-title":"Can J Physiol Pharmacol"},{"issue":"5","key":"10.1016\/j.ebiom.2025.105836_bib22","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1111\/ejn.13163","article-title":"Amylin receptor components and the leptin receptor are co-expressed in single rat area postrema neurons","volume":"43","author":"Liberini","year":"2016","journal-title":"Eur J Neurosci"},{"issue":"15","key":"10.1016\/j.ebiom.2025.105836_bib23","doi-asserted-by":"crossref","first-page":"11183","DOI":"10.1021\/acs.jmedchem.1c00565","article-title":"Development of cagrilintide, a long-acting amylin analogue","volume":"64","author":"Kruse","year":"2021","journal-title":"J Med Chem"},{"issue":"2","key":"10.1016\/j.ebiom.2025.105836_bib24","article-title":"Combined GLP-1 receptor agonist and amylin analogue pharmacotherapy to treat obesity comorbid with type 1 diabetes","volume":"1","author":"Wong","year":"2023","journal-title":"JCEM Case Rep"},{"key":"10.1016\/j.ebiom.2025.105836_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.peptides.2024.171197","article-title":"Chronic pramlintide decreases feeding via a reduction in meal size in male rats","volume":"176","author":"Kern","year":"2024","journal-title":"Peptides"},{"issue":"4","key":"10.1016\/j.ebiom.2025.105836_bib26","doi-asserted-by":"crossref","first-page":"320","DOI":"10.7570\/jomes21071","article-title":"Amylin as a future obesity treatment","volume":"30","author":"Dehestani","year":"2021","journal-title":"J Obes Metab Syndr"},{"issue":"3","key":"10.1016\/j.ebiom.2025.105836_bib27","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1345\/aph.1M210","article-title":"The role of pramlintide for weight loss","volume":"44","author":"Dunican","year":"2010","journal-title":"Ann Pharmacother"},{"issue":"3","key":"10.1016\/j.ebiom.2025.105836_bib28","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1124\/jpet.121.000567","article-title":"AM833 is a novel agonist of calcitonin family G protein-coupled receptors: pharmacological comparison with six selective and nonselective agonists","volume":"377","author":"Fletcher","year":"2021","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"10.1016\/j.ebiom.2025.105836_bib29","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/s41589-023-01393-4","article-title":"Structural insight into selectivity of amylin and calcitonin receptor agonists","volume":"20","author":"Cao","year":"2024","journal-title":"Nat Chem Biol"},{"issue":"10317","key":"10.1016\/j.ebiom.2025.105836_bib30","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1016\/S0140-6736(21)01751-7","article-title":"Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial","volume":"398","author":"Lau","year":"2021","journal-title":"Lancet"},{"issue":"10286","key":"10.1016\/j.ebiom.2025.105836_bib31","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1016\/S0140-6736(21)00845-X","article-title":"Safety, tolerability, pharmacokinetics, and pharmacodynamics of concomitant administration of multiple doses of cagrilintide with semaglutide 2.4 mg for weight management: a randomised, controlled, phase 1b trial","volume":"397","author":"Enebo","year":"2021","journal-title":"Lancet"},{"issue":"10286","key":"10.1016\/j.ebiom.2025.105836_bib32","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1016\/S0140-6736(21)00944-2","article-title":"Cagrilintide plus semaglutide for obesity management","volume":"397","author":"Becerril","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.ebiom.2025.105836_bib33","article-title":"Comparative effectiveness of GLP-1 receptor agonists on glycaemic control, body weight, and lipid profile for type 2 diabetes: systematic review and network meta-analysis","volume":"384","author":"Yao","year":"2024","journal-title":"BMJ"},{"key":"10.1016\/j.ebiom.2025.105836_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.peptides.2024.171203","article-title":"Identification and utility exploration of a highly potent and long-acting bullfrog GLP-1 analogue in GLP-1 and amylin combination therapy","volume":"177","author":"Sun","year":"2024","journal-title":"Peptides"},{"issue":"25","key":"10.1016\/j.ebiom.2025.105836_bib35","doi-asserted-by":"crossref","first-page":"18094","DOI":"10.1074\/jbc.M703544200","article-title":"Receptor activity-modifying proteins 2 and 3 have distinct physiological functions from embryogenesis to old age","volume":"282","author":"Dackor","year":"2007","journal-title":"J Biol Chem"},{"issue":"7","key":"10.1016\/j.ebiom.2025.105836_bib36","article-title":"Deficiency of RAMP1 attenuates antigen-induced airway hyperresponsiveness in mice","volume":"9","author":"Li","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ebiom.2025.105836_bib37","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.neuroscience.2019.11.036","article-title":"RAMP1 and RAMP3 differentially control amylin's effects on food intake, glucose and energy balance in male and female mice","volume":"447","author":"Coester","year":"2020","journal-title":"Neuroscience"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105836_bib61","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1186\/s12859-016-1104-8","article-title":"SUSHI: an exquisite recipe for fully documented, reproducible and reusable NGS data analysis","volume":"17","author":"Hatakeyama","year":"2016","journal-title":"BMC Bioinformatics"},{"issue":"4","key":"10.1016\/j.ebiom.2025.105836_bib38","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/s42255-021-00363-1","article-title":"A genetic map of the mouse dorsal vagal complex and its role in obesity","volume":"3","author":"Ludwig","year":"2021","journal-title":"Nat Metab"},{"key":"10.1016\/j.ebiom.2025.105836_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2022.101444","article-title":"Hypophagia induced by salmon calcitonin, but not by amylin, is partially driven by malaise and is mediated by CGRP neurons","volume":"58","author":"Boccia","year":"2022","journal-title":"Mol Metab"},{"issue":"2","key":"10.1016\/j.ebiom.2025.105836_bib39","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3758\/BF03193146","article-title":"G\u2217Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences","volume":"39","author":"Faul","year":"2007","journal-title":"Behav Res Methods"},{"issue":"3","key":"10.1016\/j.ebiom.2025.105836_bib41","doi-asserted-by":"crossref","first-page":"4863","DOI":"10.1111\/ejn.15376","article-title":"A selective role for receptor activity-modifying proteins in subchronic action of the amylin selective receptor agonist NN1213 compared with salmon calcitonin on body weight and food intake in male mice","volume":"54","author":"Arrigoni","year":"2021","journal-title":"Eur J Neurosci"},{"issue":"4","key":"10.1016\/j.ebiom.2025.105836_bib40","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1002\/oby.23374","article-title":"Beyond appetite regulation: targeting energy expenditure, fat oxidation, and lean mass preservation for sustainable weight loss","volume":"30","author":"Christoffersen","year":"2022","journal-title":"Obesity"},{"key":"10.1016\/j.ebiom.2025.105836_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.physbeh.2020.112992","article-title":"Viral depletion of calcitonin receptors in the area postrema: a proof-of-concept study","volume":"223","author":"Coester","year":"2020","journal-title":"Physiol Behav"},{"issue":"2","key":"10.1016\/j.ebiom.2025.105836_bib43","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.cmet.2019.12.012","article-title":"Calcitonin receptor neurons in the mouse nucleus tractus solitarius control energy balance via the non-aversive suppression of feeding","volume":"31","author":"Cheng","year":"2020","journal-title":"Cell Metab"},{"key":"10.1016\/j.ebiom.2025.105836_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113842","article-title":"Does receptor balance matter? - comparing the efficacies of the dual amylin and calcitonin receptor agonists cagrilintide and KBP-336 on metabolic parameters in preclinical models","volume":"156","author":"Larsen","year":"2022","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.ebiom.2025.105836_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2023.175837","article-title":"Treatment sequencing using the dual amylin and calcitonin receptor agonist KBP-336 and semaglutide results in durable weight loss","volume":"954","author":"Thorso Larsen","year":"2023","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"10.1016\/j.ebiom.2025.105836_bib46","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/bcpt.13427","article-title":"Central control of energy balance by amylin and calcitonin receptor agonists and their potential for treatment of metabolic diseases","volume":"127","author":"Zakariassen","year":"2020","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"10.1016\/j.ebiom.2025.105836_bib47","article-title":"A cross-species atlas of the dorsal vagal complex reveals neural mediators of cagrilintide\u2019s effects on energy balance","author":"Ludwig","year":"2025","journal-title":"bioRxiv"},{"issue":"6587","key":"10.1016\/j.ebiom.2025.105836_bib48","doi-asserted-by":"crossref","DOI":"10.1126\/science.abm9609","article-title":"A structural basis for amylin receptor phenotype","volume":"375","author":"Cao","year":"2022","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.ebiom.2025.105836_bib50","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0092042","article-title":"Prolonged calcitonin receptor signaling by salmon, but not human calcitonin, reveals ligand bias","volume":"9","author":"Andreassen","year":"2014","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.ebiom.2025.105836_bib51","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0196-9781(99)00208-9","article-title":"Amylin receptors mediate the anorectic action of salmon calcitonin (sCT)","volume":"21","author":"Lutz","year":"2000","journal-title":"Peptides"},{"issue":"2","key":"10.1016\/j.ebiom.2025.105836_bib52","first-page":"129","article-title":"Mechanisms of calcitonin induction of prolonged activation of adenylate cyclase in human cancer cells","volume":"9","author":"Michelangeli","year":"1983","journal-title":"J Cyclic Nucleotide Protein Phosphor Res"},{"issue":"2","key":"10.1016\/j.ebiom.2025.105836_bib53","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/ijo.2009.238","article-title":"Davalintide (AC2307), a novel amylin-mimetic peptide: enhanced pharmacological properties over native amylin to reduce food intake and body weight","volume":"34","author":"Mack","year":"2010","journal-title":"Int J Obes"},{"issue":"3","key":"10.1016\/j.ebiom.2025.105836_bib54","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.neuron.2020.11.010","article-title":"Area postrema cell types that mediate nausea-associated behaviors","volume":"109","author":"Zhang","year":"2021","journal-title":"Neuron"},{"issue":"2","key":"10.1016\/j.ebiom.2025.105836_bib55","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.apsb.2021.07.028","article-title":"Modulating effects of RAMPs on signaling profiles of the glucagon receptor family","volume":"12","author":"Shao","year":"2022","journal-title":"Acta Pharm Sin B"},{"issue":"9","key":"10.1016\/j.ebiom.2025.105836_bib56","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aaw2778","article-title":"Multiplexed analysis of the secretin-like GPCR-RAMP interactome","volume":"5","author":"Lorenzen","year":"2019","journal-title":"Sci Adv"},{"issue":"38","key":"10.1016\/j.ebiom.2025.105836_bib57","doi-asserted-by":"crossref","first-page":"29602","DOI":"10.1074\/jbc.M004534200","article-title":"Visualization of the calcitonin receptor-like receptor and its receptor activity-modifying proteins during internalization and recycling","volume":"275","author":"Kuwasako","year":"2000","journal-title":"J Biol Chem"},{"issue":"45","key":"10.1016\/j.ebiom.2025.105836_bib58","doi-asserted-by":"crossref","first-page":"42182","DOI":"10.1074\/jbc.M107323200","article-title":"Agonist-promoted internalization of a ternary complex between calcitonin receptor-like receptor, receptor activity-modifying protein 1 (RAMP1), and beta-arrestin","volume":"276","author":"Hilairet","year":"2001","journal-title":"J Biol Chem"},{"issue":"10","key":"10.1016\/j.ebiom.2025.105836_bib59","doi-asserted-by":"crossref","first-page":"9297","DOI":"10.1074\/jbc.M413786200","article-title":"Novel function for receptor activity-modifying proteins (RAMPs) in post-endocytic receptor trafficking","volume":"280","author":"Bomberger","year":"2005","journal-title":"J Biol Chem"},{"issue":"25","key":"10.1016\/j.ebiom.2025.105836_bib60","doi-asserted-by":"crossref","first-page":"23926","DOI":"10.1074\/jbc.M501751200","article-title":"Receptor activity-modifying protein (RAMP) isoform-specific regulation of adrenomedullin receptor trafficking by NHERF-1","volume":"280","author":"Bomberger","year":"2005","journal-title":"J Biol Chem"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396425002804?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396425002804?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T06:02:56Z","timestamp":1755496976000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396425002804"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":60,"alternative-id":["S2352396425002804"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2025.105836","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cagrilintide lowers bodyweight through brain amylin receptors 1 and 3","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2025.105836","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105836"}}